je.st
news
Newron Receives Complete Response Letter From US FDA For Xadago (safinamide)
2016-03-30 07:24:45| drugdiscoveryonline Home Page
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, and its partners Zambon S.p.A. and US WorldMeds announced recently that a complete response letter from the FDA has been received for safinamide
Tags: complete
response
letter
receives
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||